Legislative Activity

This bill modifies the required content for the annual report on the Navy Shipyard Infrastructure Optimization Program. Specifically, it mandates that the report must now include details on the incorporation of digital infrastructure and platforms alongside physical shipyard updates. This ensures the Navy reports on the integration of modern digital systems in its infrastructure modernization efforts.

This bill authorizes the Secretary of Defense to establish a program supporting the defense biotechnology supply chain. The program aims to strengthen military readiness by developing and scaling up promising bio-based materials, fuels, and chemicals from military research. It focuses on reducing reliance on vulnerable foreign supply lines through applied research, prototyping, and public-private partnerships. The authority to run this program will automatically expire ten years after enactment unless extended by the President.

This bill expands an existing Department of Defense program focused on overcoming supply chain challenges in contested environments. It specifically mandates the inclusion of commercial additive manufacturing (3D printing) facilities in demonstration and prototyping efforts. Furthermore, the legislation extends the deadline for this program's activities until December 31, 2030.

This bill mandates that the Department of Defense conduct biennial assessments of nutrition standards across all military departments to ensure they align with available food options. It also requires the development and public release of a comprehensive plan to increase access to nutritious food on military installations. The goal is to improve the health and readiness of service members by enhancing the quality and availability of on-base food choices.

This bill directs the Chairman of the Joint Chiefs of Staff to conduct a feasibility study on integrating militarily relevant applications of emerging biotechnology into military wargaming exercises. The study must assess how new biotech could affect soldier capabilities, strategic materials, and potential adversary use. The resulting report, due within 180 days, will recommend necessary updates to ensure wargames reflect current and future technological realities.

This bill directs the Department of Defense (DoD) to establish clear guidance for private entities on how to demonstrate that their biobased products meet military requirements. It also mandates an audit by the Comptroller General to review DoD procurement standards for any unintentional exclusion of biobased products. The goal is to ensure fair evaluation and increase the adoption of biologically derived products within the DoD supply chain.

This bill mandates the Department of Defense to establish dedicated Blast Safety Officer positions across the Army, Navy, Marine Corps, Air Force, and Space Force by September 30, 2026. These officers will be responsible for monitoring and enforcing safety standards during explosive exercises to reduce service members' exposure to dangerous blast pressure. They will have the authority to halt dangerous drills, provide pre-exercise safety briefings, and investigate any overpressure incidents. This measure aims to proactively protect military personnel from potential long-term health risks associated with blast exposure.

The Investing in Children Before Missiles (ICBM) Act pauses the troubled Sentinel missile replacement program due to significant cost overruns and delays. The bill mandates redirecting unspent research and development funds from the Sentinel and W87-1 warhead programs directly to the Department of Education for elementary and secondary school funding. Furthermore, it requires an independent study to analyze extending the life of the existing Minuteman III missiles until at least 2050 as an alternative to the new ICBM system.

The State-Based Universal Health Care Act of 2025 empowers individual states to design and implement their own comprehensive universal health coverage systems. States can apply for a federal waiver to bypass most existing federal health insurance rules, including major parts of the ACA, Medicare, and Medicaid. In exchange for waiving federal funding, the federal government will transfer equivalent funds to the state, provided the state commits to covering at least 95% of its residents within five years and maintains budget neutrality for the federal government.

The Prescription Drug Price Relief Act of 2025 establishes a process for identifying brand-name drugs priced excessively high in the U.S. by comparing them to international prices and other factors. If a drug is deemed overpriced, the Act immediately revokes its government-granted monopolies, allowing generic competition through open licensing. Manufacturers will face strict new annual reporting requirements regarding pricing, R&D costs, and marketing, with penalties for non-compliance.

The Global Fairness in Drug Pricing Act aims to significantly lower prescription drug costs for Americans. It directs the HHS to establish "most-favored-nation" price targets based on international rates and enhances safe importation options. Additionally, the bill mandates enforcement actions against anticompetitive drug manufacturer behavior and requires a study on global pricing discrimination.

The Drain the Swamp Act officially codifies Executive Order 13989 into federal statute. This action elevates the directives and requirements of the Executive Order to the full force and effect of law passed by Congress. The bill essentially locks in the established rules, making them permanent federal law.

The Telehealth Coverage Act of 2025 aims to permanently expand access to telehealth services under Medicare by making temporary flexibilities permanent, including coverage for audio-only services and removing certain in-person visit requirements. The bill also extends flexibilities for hospital-at-home care and establishes new requirements for language access and documentation for remote services, such as hospice recertification. Furthermore, it expands access to virtual programs for diabetes prevention and mandates education for providers on screening for medication-induced movement disorders via telehealth.

This resolution expresses support for comprehensive political reforms aimed at restoring public trust in government. These reforms include measures such as prohibiting contributions from PACs and lobbyists, imposing lifetime lobbying bans on members of Congress, and banning members from trading stocks. The resolution also supports establishing term limits for members of Congress and Supreme Court Justices, as well as instituting a binding code of ethics for Supreme Court Justices.

The "Supreme Court Term Limits and Regular Appointments Act of 2025" introduces 18-year term limits for Supreme Court Justices, ensuring regular appointments every two years following a Presidential election. It establishes a system for Senior Justices to temporarily fill vacancies and stipulates that Senate inaction on a nominee within 120 days results in automatic approval. Justices appointed before the enactment of this law are exempt from term limits and active panel rules. The nine most junior Justices will form the active panel.

The "Repeal the TikTok Ban Act" repeals the "Protecting Americans from Foreign Adversary Controlled Applications Act", effectively nullifying any prior bans or restrictions on applications like TikTok that were designated as foreign adversary controlled.

The "Extend the TikTok Deadline Act" extends the deadline for the divestment of TikTok from its parent company, ByteDance, from 270 days to 540 days. This amends the Protecting Americans from Foreign Adversary Controlled Applications Act.